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Abstract
Innate immune recognition is the first line of host defense against invading microorganisms. It is a based on the detection,
by pattern recognition receptors (PRRs), of invariant molecular signatures that are unique to microorganisms. TLR2 is a PRR
that plays a major role in the detection of Gram-positive bacteria by recognizing cell envelope lipid-linked polymers, also
called macroamphiphiles, such as lipoproteins, lipoteichoic acids and mycobacterial lipoglycans. These microbe-associated
molecular patterns (MAMPs) display a structure based on a lipid anchor, being either an acylated cysteine, a glycosylated
diacylglycerol or a mannosyl-phosphatidylinositol respectively, and having in common a diacylglyceryl moiety. A fourth
class of macroamphiphile, namely lipoglycans, whose lipid anchor is made, as for lipoteichoic acids, of a glycosylated
diacylglycerol unit rather than a mannosyl-phosphatidylinositol, is found in Gram-positive bacteria and produced by certain
Actinobacteria, including Micrococcus luteus, Stomatococcus mucilaginosus and Corynebacterium glutamicum. We report here
that these alternative lipoglycans are also recognized by TLR2 and that they stimulate TLR2-dependant cytokine production,
including IL-8, TNF-a and IL-6, and cell surface co-stimulatory molecule CD40 expression by a human macrophage cell line.
However, they differ by their co-receptor requirement and the magnitude of the innate immune response they elicit. M.
luteus and S. mucilaginosus lipoglycans require TLR1 for recognition by TLR2 and induce stronger responses than C.
glutamicum lipoglycan, sensing of which by TLR2 is dependent on TLR6. These results expand the repertoire of MAMPs
recognized by TLR2 to lipoglycans based on a glycosylated diacylglycerol lipid anchor and reinforce the paradigm that
macroamphiphiles based on such an anchor, including lipoteichoic acids and alternative lipoglycans, induce TLR2-
dependant innate immune responses.
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Introduction
The innate immune system is genetically programmed to detect
molecular signatures of microbes via a limited number of germline-
encoded pattern recognition receptors (PRRs) [1,2,3,4,5,6]. The
signatures seen as foreign are structural motifs, referred to as
pathogen/microbe-associated molecular patterns (PAMPs/
MAMPs), which are unique to microorganisms and relatively
invariant in most microorganisms of a given class. The molecular
pattern recognized by PRRs is usually a small but conserved part
of a macromolecule of microbial origin, such as the lipid anchor in
bacterial macroamphiphiles, and which might be repeated such as
monomers in peptidoglycan or in nucleic acids [7,8].
Bacterial macroamphiphiles, i.e. cell envelope lipid-linked
polymers [9,10], namely Gram-negative bacterial lipopolysaccha-
ride (LPS), Gram-positive bacteria lipoteichoic acid (LTA),
lipoproteins and mycobacterial lipoglycans, evidently meet
PAMP/MAMP criteria and are well suited to innate immune
recognition. They are mostly recognized via their lipid anchor by a
family of PRRs, named Toll-like receptors (TLRs). TLR
extracellular domains, which have leucine-rich repeat modules,
adopt a horseshoe-like shape structure and are responsible for
PAMP/MAMP binding [11,12]. Their intracellular signalling
domains trigger innate immune responses through NF-kB-
dependent and IFN regulatory factor-dependant signalling path-
ways [1,2,3,4]. Lipoproteins, LTA and mycobacterial lipoglycans,
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based on a lipid anchor being either an acylated cysteine (a), a
glycosylated diacylglycerol (b) or a mannosyl-phosphatidylinositol
(c) respectively, and having in common a diacylglyceryl moiety
(Figure 1), are recognized by TLR2. The latter generally functions
as a heterodimer with either TLR1 or TLR6, which is involved in
discrimination of the acylation state of lipoproteins, its best
characterized agonists [13,14,15]. Structure/function relationship
studies, corroborated by the reports of the structures of several
TLR2-lipopeptide complexes determined by X-ray crystallogra-
phy, have established that the acylated cysteinyl moiety is the
structure recognized by the receptors and that triacylated
lipoproteins are preferentially recognized by the TLR2/TLR1
complex, whereas diacylated lipoproteins are recognized by the
TLR2/TLR6 complex [16,17]. In the crystal structure of a TLR1-
TLR2 heterodimer in complex with the model lipopeptide
Pam3CSK4 [16] (Figure 1), the triacylated lipopeptide appears
to form a bridge between TLR2 and TLR1 with the two ester-
bound fatty acyl chains of the S-diacylglyceryl moiety inserted
deep into a pocket in the hydrophobic core of TLR2, the third
amide-linked acyl chain occupying a hydrophobic channel at the
surface of TLR1 and the conserved polar head located at the
region of contact between the two receptors. Crystal structure of a
TLR2-TLR6-diacylated lipopeptide complex reveals that the
lipid-binding channel of TLR6 is blocked by two phenylalanines
that hamper the binding of any fatty acid chain [17]. Besides
lipoproteins, the majority of low G+C Gram-positive bacteria
(Firmicutes) produce LTA [10,18,19] that are composed of a lipid
anchor, made of a diacylglycerol (DAG) unit substituted by a di- or
tri-glycoside. In contrast, high G+C Gram-positive bacteria of the
suborders Corynebacterineae, including mycobacteria, and Pseudono-
cardineae do not produce LTA but rather lipoglycans, with
structures based on a multi-acylated mannosyl-phosphatidyl-myo-
inositol (MPI) anchor [10,19,20,21,22,23] (Figure 1). As described
for diacylated lipopeptides, heterodimerization of TLR2 with
TLR6 seems to be important for LTA recognition [24,25]. A
crystal structure of TLR2 in complex with Streptococcus pneumoniae
LTA showed that the two fatty acyl chains of the DAG unit are
inserted in the hydrophobic pocket of TLR2 [17]. Mycobacterial
tri- and tetra-acylated lipoglycans are instead recognized by the
TLR2-TLR1 heterodimer [26]. It is proposed, by analogy with
lipopeptides, that in the case of tri-acylated lipoglycans, both fatty
acids of the DAG unit are inserted in the hydrophobic pocket of
TLR2 while the third acyl chain esterfying the mannosyl unit of
the MPI anchor is inserted in the hydrophobic channel at the
surface of TLR1 [8].
A fourth class of macroamphiphiles, namely lipoglycans whose
lipid anchor is made, as for LTA, of a glycosylated DAG unit
rather than a MPI, is found in some Gram-positive Actinobacteria,
including Micrococcus luteus [27,28], Stomatococcus mucilaginosus [29]
and Corynebacterium glutamicum [30,31] (Figure 1b). Here, we report
Figure 1. Structure of the lipid anchor of bacterial macroamphiphiles. CgLM, Corynebacterium glutamicum lipomannan; DAG, diacylglycerol;
FSL-1, synthetic N-terminal part of lipopoprotein LP44 of Mycoplasma salivarum; MlLM, Micrococcus luteus lipomannan; MPI, mannosyl-phosphatidyl-
myo-inositol; MsLM, Mycobacterium smegmatis lipomannan; PGP, polyglycerolphosphate; SaLTA, Staphylococcus aureus lipoteichoic acid; The
available evidence [29] suggests the structure of Stomatococcus mucilaginosus lipomannan (SmLM) is very similar to that of MlLM.
doi:10.1371/journal.pone.0081593.g001
DAG-Based Lipoglycans Are MAMPs
PLOS ONE | www.plosone.org 2 November 2013 | Volume 8 | Issue 11 | e81593
DAG-Based Lipoglycans Are MAMPs
PLOS ONE | www.plosone.org 3 November 2013 | Volume 8 | Issue 11 | e81593
that these alternative lipoglycans are also recognized by TLR2 and
that they stimulate TLR2-dependant cytokine production and cell
surface co-stimulatory molecule CD40 expression by a human
macrophage cell line. Our results expand the repertoire of
MAMPs recognized by TLR2 and reinforce the paradigm that
macroamphiphiles based on a glycosylated DAG anchor, such as
LTA and alternative lipoglycans, are ligands of TLR2.
Results
Lipoglycans based on a glycosylated DAG anchor (i.e. DAG-
based lipoglycans) were purified from M. luteus [27,28], C.
glutamicum [30] and S. mucilaginosus [29]. These lipoglycans are
lipomannans (LM) (Figure 1) and will be subsequently termed
MlLM, CgLM and SmLM respectively.
Signaling via TLR2
We first tested the ability of MlLM, CgLM and SmLM to
stimulate HEK293 cells stably transfected with human TLR2 and
CD14 genes and a NF-kB-inducible reporter system (HEK-TLR2
cells). The synthetic lipopeptides Pam3CSK4 and FSL-1, Mycobac-
terium smegmatis LM (MsLM) and Staphylococcus aureus LTA (SaLTA)
were used as reference ligands of TLR2 based on a lipid anchor
being either an acylated cysteine, a MPI or a glycosylated DAG
respectively (Figure 1). Interestingly, MlLM, SmLM and CgLM
each induced NF-kB activation in a dose-dependent fashion
(Figure 2A) and their activity was inhibited by an anti-TLR2
antibody (Figure 2B). However, the magnitude of activation varied
between the different ligands of TLR2. Synthetic lipopeptides
were the strongest agonists with an EC50 in the range of 1 ng/ml,
followed by MlLM and SmLM (EC50 , 10 ng/ml), MsLM (EC50
, 30 ng/ml) and finally SaLTA and CgLM (EC50 , 100 ng/ml).
TLR2 activation by MlLM, CgLM and SmLM was dependent
on the presence of a native acylated lipid anchor since they failed
to activate NF-kB upon deacylation (Figure 2C). This result is in
agreement with structure/function relationships studies and crystal
structures that previously revealed that fatty acids are critical for
lipopeptides, LTA and mycobacterial lipoglycans signaling via and
binding to TLR2 [7,8,16,17]. The requirement of TLR1 or TLR6
for recognition of MlLM, CgLM and SmLM by TLR2 was tested
using blocking antibodies. As expected for the reference ligands,
the activity of the triacylated Pam3CSK4 and MsLM was clearly
dependent on TLR1, whereas that of the diacylated FSL-1
lipopeptide and SaLTA was dependent on TLR6 (Figure 2B). The
TLR2-dependant activation of NF-kB by CgLM was strongly,
although not completely, inhibited by the anti-TLR6 antibody and
moderately inhibited by anti-TLR1 antibody. Surprisingly, activity
of diacylated MlLM and SmLM was almost completely inhibited
by anti-TLR1 but not anti-TLR6 antibodies (Figure 2B).
Activation of THP-1 human macrophage cell line
We then investigated the capacity of DAG-based lipoglycans to
activate the human THP-1 monocyte/macrophage cells, using a
cell line derivative that stably expresses a NF-kB-inducible
reporter system. MlLM, SmLM and CgLM induced NF-kB
activation in a dose-dependent fashion (Figure 3A) and their
activity was strongly inhibited by an anti-TLR2 antibody (Figure
3B). The magnitude of activation of the different macroamphi-
philes followed the hierarchy observed with HEK-TLR2 cells
(Figure 2A). Lipopeptides were the most stimulatory with an EC50
below 10 ng/ml, followed by the TLR2-TLR1 signaling lipogly-
cans SmLM, MsLM and MlLM (EC50 below 100 ng/ml), and
finally the TLR2-TLR6 signaling SaLTA and CgLM (EC50 above
300 ng/ml).
Activation of innate immunity ultimately regulates adaptive
immunity, most particularly via the production of cytokines and
the expression of co-stimulatory molecules by antigen-presenting
cells [1,2,3,4]. THP-1 cells being strong producers of IL-8 [32],
this cytokine was analyzed first. All the macroamphiphiles induced
a dose-dependent production of IL-8 (Figure 3C) that was almost
completely abrogated by an anti-TLR2 antibody (Figure 3D).
However, MlLM and SmLM were the most potent inducers,
except for synthetic lipopeptides, a plateau of around 10 ng/ml of
IL-8 being reached at a concentration of DAG-based lipoglycans
of 1 mg/ml. SaLTA and CgLM were much weaker inducers,
whereas MsLM showed an intermediate potency (Figure 3C).
Similar data were obtained with TNF-a (Figure 3E) and IL-6
(Figure 3G), although these cytokines were produced by THP-1
cells in lower amount. It is worth noting that a TNF-a production
plateau of around 100 pg/ml was reached for an MlLM or SmLM
concentration of 100 ng/ml only (Figure 3E). An 1 log increase in
concentration was required for MsLM to reach the same effect. A
2 log increase in concentration of SaLTA and CgLM led to a
production of TNF-a of around 10 pg/ml only. TNF-a (Figure
3F) and IL-6 (Figure 3H) production elicited by the different
stimuli was strongly and significantly inhibited by an anti-TLR2
antibody, except for SaLTA and CgLM (which induced insuffi-
cient amount of cytokines for accurate determination). These data
confirm the earlier observation that CgLM stimulated TNF-a
production by the human macrophage cell line THP-1 [31].
Finally, all the TLR2 ligands tested were able, at a concentra-
tion of 1 mg/ml, to induce the expression of the cell surface co-
stimulatory molecule CD40 but failed to induce MHCII (Figure
4). Again, DAG-based MlLM and SmLM were the most
stimulatory lipoglycans. SaLTA and CgLM were the least
stimulatory ligands whereas MsLM showed an intermediate
potency. Induction of CD40 expression by the different stimuli
was partially inhibited by an anti-TLR2 antibody (Figure 4).
Discussion
Bacterial cell wall macroamphiphiles are detected by the innate
immune system as foreign molecular signatures [8]. LPS is
recognized by TLR4-MD2 whereas lipoproteins, LTA, and
mycobacterial lipoglycans are recognized by TLR2-TLR1/
TLR6. Structure/function relationships studies and crystal struc-
tures have established that macroamphiphiles are mostly recog-
nized via their lipid anchor, most particularly through binding of
fatty acids into hydrophobic pockets of the receptors [12].
Lipoproteins, LTA, and mycobacterial lipoglycans display a
structure based on a lipid anchor consisting in an acylated
cysteine, a glycosylated DAG or a MPI respectively. Besides these
Figure 2. DAG-based lipoglycans are recognized by TLR2 in cooperation with TLR1 or TLR6. A, C) HEK-TLR2 cells were incubated with the
various stimuli at a concentration ranging from 0.1 to 1000 ng/ml. B) HEK-TLR2 cells were pre-incubated or not for 30 min at 37uC before stimuli
addition with various monoclonal antibodies: anti-TLR2 (5 mg/ml), anti-TLR1 (10 mg/ml), anti-TLR6 (10 mg/ml) or IgG1 isotype control (10 mg/ml). FSL-1
was tested at a concentration of 1 ng/ml, Pam3CSK4 and MsLM at 10 ng/ml, SmLM at 50 ng/ml, MlLM and SaLTA at 100 ng/ml and CgLM at 300 ng/
ml. In C, deacylated molecules (+) were prepared by treating native molecules (2) with 2M NH4OH for 2h at 110uC. NF-kB activation was determined
by reading OD at 630 nm. The results are mean 6 SD of triplicate wells and are representative of at least three separate experiments. ***, P,0.001.
Iso ctrl, isotype control, n.i., not induced.
doi:10.1371/journal.pone.0081593.g002
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last three classes of macroamphiphiles, a fourth one is found in
Gram-positive bacteria, namely lipoglycans whose lipid anchor is
made of a glycosylated DAG unit.
We report here that representatives of these alternative DAG-
based lipoglycans, MlLM, SmLM and CgLM, are also recognized
by TLR2 and that they stimulate TLR2-dependant cytokine
production, including IL-8, TNF-a and IL-6, and cell surface co-
stimulatory molecule CD40 expression by a human macrophage
cell line. However, they differ in their co-receptor requirement and
the magnitude of the innate immune response they elicit.
As expected for a diacylated molecule, recognition of CgLM by
TLR2 was mostly dependent on TLR6, although it was partially,
but significantly, inhibited by an anti-TLR1 antibody. More
surprisingly, MlLM and SmLM recognition was almost completely
dependent on TLR1. These results are in sharp contrast with the
paradigm of receptor usage as a function of the acylation pattern
since triacylated lipoproteins are preferentially recognized by the
TLR2/TLR1 complex, whereas diacylated lipoproteins are
recognized by the TLR2/TLR6 complex [13,14,15]. However,
it has been also previously described that in addition to the
acylation pattern, the nature of the amino acids of the peptidic
chain of lipopeptides can modulate the specificity of the
recognition by TLR2 heterodimers [33,34]. A similar phenome-
non seems to apply with DAG-based lipoglycans, where the
acylation pattern is not sufficient to dictate the TLR2 heterodimer
usage. The underlying molecular bases remain to be uncovered,
however these results further demonstrate that the pattern
recognized by the receptors is not strictly restricted to the lipid
moiety of lipopeptides or lipoglycans, but also involves in part the
hydrophilic moiety of these TLR2 agonists. We previously
established that the (a1R6)-mannopyranosyl backbone, which is
a highly conserved structural feature of MPI-based lipoglycans, is
an integral part of the pattern recognized by TLR2 [35]. Similarly,
the mannan chain is required for DAG-based lipoglycan activity
since DAG alone (dipalmitin) did not activate TLR2 (not shown).
Interestingly, SmLM and MlLM that induce signalling via
TLR2-TLR1 were much stronger activators than CgLM that
activates via TLR2-TLR6. Activity of SlLM and MlLM was even
higher than that of the MPI-based lipoglycan MsLM, which
contributes to the innate immune detection of M. smegmatis by
TLR2-TLR1 [32]. In contrast, CgLM activity was weaker and
similar to that of the TLR2-TLR6 agonist SaLTA. The weaker
activity of CgLM and SaLTA was not a result of a low expression
of TLR6 in THP-1 cells. Indeed, TLR6 expression was confirmed
by flow cytometry analysis (not shown). Moreover, the TLR2-
TLR6 ligand FSL-1 lipopeptide was highly stimulatory in these
cells. An interesting correlate of the difference in response to
CgLM compared to MlLM and SmLM is that the former has a
Figure 3. DAG-based lipoglycans stimulate TLR2-dependant NF-kB activation and IL-8, TNF-a and IL-6 production by human THP-1
monocyte/macrophage cell line. A) THP-1 cells were incubated with the various stimuli at a concentration ranging from 0.1 to 1000 ng/ml. C, E,
G) THP-1 cells were incubated with the various stimuli at a concentration ranging from 0.1 to 10 mg/ml. B, D, F, H) THP-1 cells were pre-incubated or
not for 30 min at 37uC with 10 mg/ml of anti-TLR2 or IgG1 isotype control antibodies and stimulated overnight with the different TLR2 ligands. FSL-1,
Pam3CSK4 FSL-1, MsLM, MlLM, SmLM were tested at a concentration of 1 mg/ml, SaLTA and CgLM at 10 mg/ml. In A and B, NF-kB activation was
determined by reading OD at 630 nm. In C to H, cytokines were assayed in the culture supernatant by sandwich ELISA. The results are mean6 SD of
triplicate wells and are representative of at least three separate experiments. 10x and 30x mean that the concentration of cytokine detected is
amplified 10 and 30 fold respectively. *, P,0.05; **, P,0.01; ***, P,0.001. n.i., not induced.
doi:10.1371/journal.pone.0081593.g003
Figure 4. DAG-based lipoglycans stimulate TLR2-dependant cell surface co-stimulatory molecule CD40 but not MHCII expression
by human THP-1 monocyte/macrophage cell line. THP-1 cells were pre-incubated or not for 30 min at 37uC with 10 mg/ml of anti-TLR2 or IgG1
isotype control antibodies and stimulated overnight with the different TLR2 ligands at a concentration of 1 mg/ml. CD40 (A) and MHC-II (B) expression
was monitored by flow cytometry. One representative experiment (from three repeats) is shown. n.i., not induced.
doi:10.1371/journal.pone.0081593.g004
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distinctive charged a-glucopyranosyluronic residue proximal to
the DAG anchor [30] rather than an uncharged mannosyl residue.
Kang et al. [17] reported a crystal structure of TLR2 in complex
with S. pneumoniae LTA, where the two fatty acyl chains of the
DAG unit are inserted in the hydrophobic pocket of TLR2.
Interestingly, although S. pneumoniae LTA was found by the authors
to bind TLR2 with high affinity, in contrast to lipopeptides, it did
not induce heterodimerization of the extracellular domains of
TLR2 and TLR6. Although requiring TLR6 for activity, CgLM,
similarly to S. pneumoniae LTA, may bind TLR6 with a weak
affinity, and this might be correlated to the lower pro-inflamma-
tory activity observed for LTA molecules [7] and CgLM as
compared to lipopeptides. Nevertheless, the low affinity for TLR6
is most probably partly compensated in physiological conditions by
the usage of soluble or membrane-anchored accessory receptors,
such as CD14, LBP or CD36, that increase the bioavailability of
the ligands [36,37,38]. As such, it is worth noting that cytokine
production elicited by the different stimuli was investigated in the
present study in non-differentiated THP-1 cells; in PMA-
differentiated THP-1 cells, SaLTA was found to induce much
higher concentrations of pro-inflammatory cytokines, although still
less than the Pam3CSK4 lipopeptide [39].
In conclusion, our results expand the repertoire of MAMPs
recognized by TLR2 to DAG-based lipoglycans and confirm the
major role played by this receptor in the detection of Gram-
positive bacteria [40]. Moreover, they reinforce the paradigm that
macroamphiphiles based on a glycosylated DAG lipid anchor,
such as LTA and alternative lipoglycans, induce TLR2-dependant
innate immune responses. Although the diacylglyceryl unit, which
is common to all the macroamphiphiles recognized by TLR2, is
also found in lipids of higher eukaryotes, its substitution by a
glycosylated polyglycerolphosphate chain in LTA, a (a1R6)-
mannopyranosyl chain in alternative lipoglycans, a (a1R6)-
mannopyranosyl chain linked to an acylated mannosyl-phosphoi-
nositol in mycobacterial lipoglycans or a cysteine in lipopeptides/
lipoproteins make the resulting molecules unique signatures of
bacteria.
Materials and Methods
Lipoglycan purification – TLR2 ligands
DAG-based lipoglycans were purified as previously described
from M. luteus (MlLM) [27,28], C. glutamicum (CgLM) [30] and S.
mucilaginosus (SmLM) [29]. MPI-based lipomannan was purified
from Mycobacterium smegmatis (MsLM) [26]. Pam3CSK4, FSL-1 and
SaLTA were purchased from InvivoGen. Lipoglycans, lipopep-
tides and LTA were deacylated by incubating with 2M NH4OH
for 2h at 110uC.
HEK-TLR2 experiments
The HEK-BlueTM-2 cell line (InvivoGen), a derivative of
HEK293 cells that stably expresses the human TLR2 and CD14
genes along with a NF-kB-inducible reporter system (secreted
alkaline phosphatase) was used according to the manufacturer’s
instruction. The different stimuli were added, at concentrations
indicated in the figure legends, in 96-wells plates and cells were
then distributed at 56104 cells per well in 200 ml DMEM culture
medium (Lonza). Alkaline phosphatase activity was measured after
18 h by mixing 20 ml of the culture supernatant and 180 ml of
Quanti-BlueTM, and reading O.D. at 630 nm. To investigate the
TLR dependence of stimuli activity, HEK-TLR2 cells were pre-
incubated for 30 min at 37uC, before stimuli addition, with various
antibodies: 5 mg/ml of monoclonal anti-TLR2 (clone T2.5,
InvivoGen) or 10 mg/ml monoclonal anti-TLR1 (Clone H2G2,
InvivoGen), monoclonal anti-TLR6 (Clone C5C8, InvivoGen) or
an IgG1 isotype control (eBioscience).
THP-1 experiments
THP-1-DualTM cells (Invivogen), derivatives of THP-1 mono-
cyte/macrophage human cells that stably express a NF-kB-
inducible reporter system (secreted alkaline phosphatase), were
used according to the manufacturer’s instruction. The different
stimuli were added, at concentrations indicated in the figure
legends, in 96-wells plates and cells were then distributed at 105
cells per well in 200 ml RPMI 1640 culture medium (Lonza). After
18 h, NF-kB activation was measured as described above and
cytokines were assayed in the culture supernatant by sandwich
ELISA using commercially available kits (eBioscience). To
investigate TLR2 dependence, cells were pre-incubated for 30
min at 37uC, before stimuli addition, with 10 mg/ml of anti-TLR2
monoclonal antibody (clone T2.5, InvivoGen) or isotype control
(IgG1, eBioscience). For monitoring CD40 and MHC-II expres-
sion, cells were harvested and resuspended in Dubelco’s PBS,
0.5% BSA and labelled with CD40-PE or MHC-II-FITC
conjugated antibody (Beckman Coulter). Cells were subjected to
flow cytometry analysis by using the CellQuest software on a flow
cytometer (FACSCalibur; Becton Dickinson).
Statistical analysis
Results are expressed as a mean 6 SD and were analyzed using
One-way analysis of variance followed by Tukey test to determine
significant differences between samples.
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